8-K – Page 706 – China Stock Advice

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Skystar to Present at the Brean Murrayrret & 2009 China Growthnference XI'AN, CHINA November 11 , 2009ystar Bio-Pharmaceuticalmpanyystar@tpg-ir.com To request a one-on-one meeting or to beded toystars email list, pleasentact Brandi Floberg atoutystar Bio-Pharmaceuticalmpany http://www.skystarbio-pharmaceutical.comystar is a China-based developer and distributor of veterinary healthcare and medicalre products.ystar has four product lines (veterinary medicines, micro-organisms, vaccines]

By info| 2016-02-05T04:55:56+00:00 November 12th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2009-11-12, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Skystar to Present at the Brean Murrayrret &

[Skystar to Present at the Brean Murrayrret & 2009 China Growthnference XI'AN, CHINA November 11 , 2009ystar Bio-Pharmaceuticalmpanyystar@tpg-ir.com To request a one-on-one meeting or to beded toystars email list, pleasentact Brandi Floberg atoutystar Bio-Pharmaceuticalmpany http://www.skystarbio-pharmaceutical.comystar is a China-based developer and distributor of veterinary healthcare and medicalre products.ystar has four product lines (veterinary medicines, micro-organisms, vaccines]

By info| 2016-02-05T04:56:27+00:00 November 12th, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 2009-11-12, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

HPJ [Highpower International] 8-K: (Original Filing)

[Hong Kong Highpower Technology Reports Third Quarter 2009 Financial Results New York & Shenzhen ., November 12 , 200 9 – Hong Kong Highpower Technology, Inc. ( NYSE Amex : HPJ) Business Highlights · Earned net income of $0.18 per diluted share for third quarter 2009, an 800% increase year-over-year, and 157% increase sequentially; · Generated gross margins of 25%] [Delaware 001-34098 20-4062622 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) Building A1, Luoshan Industrial Zone, Shanxia, Pinghu, Longgang, Shenzhen, Guangdong, 518111, China (86) 755-89686238 (Former name or former address, if changed since last report.) ¨ ¨ ¨ ¨ Item 2.02 Results of Operations and Financial Condition. On November 12, 2009, Hong Kong Highpower Technology, Inc. (the “Company”)]

By info| 2016-03-14T11:57:39+00:00 November 12th, 2009|Categories: Chinese Stocks, HPJ, SEC Original|Tags: 0001368308, 2009-11-12, 3690, 8-K, HPJ, MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT and SUPPLIES|0 Comments

HPJ [Highpower International] 8-K: Hong Kong Highpower Technology Reports Third Quarter 2009

[Hong Kong Highpower Technology Reports Third Quarter 2009 Financial Results New York & Shenzhen ., November 12 , 200 9 – Hong Kong Highpower Technology, Inc. ( NYSE Amex : HPJ) Business Highlights · Earned net income of $0.18 per diluted share for third quarter 2009, an 800% increase year-over-year, and 157% increase sequentially; · Generated gross margins of 25%] [Delaware 001-34098 20-4062622 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) Building A1, Luoshan Industrial Zone, Shanxia, Pinghu, Longgang, Shenzhen, Guangdong, 518111, China (86) 755-89686238 (Former name or former address, if changed since last report.) ¨ ¨ ¨ ¨ Item 2.02 Results of Operations and Financial Condition. On November 12, 2009, Hong Kong Highpower Technology, Inc. (the “Company”)]

By info| 2016-03-14T11:59:17+00:00 November 12th, 2009|Categories: Chinese Stocks, HPJ, Webplus ver|Tags: 0001368308, 2009-11-12, 3690, 8-K, HPJ, MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT and SUPPLIES|0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: (Original Filing)

[China Automotive Systems Reports 2009 Third Quarter Results - ， - Q3 EPS $0.28 - Free Cash Flow $15.5 million in first 9 months - WUHAN, China, November 12, 2009 -- China Automotive Systems, Inc., (the "Company"), (NASDAQ: CAAS) 2009 Third Quarter Highlights: -- Net sales increased organically 75% YoY to a new quarterly sales record of $64.7 million; --] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event reported): November 12, 2009 (November 12, 2009) China Automotive Systems, Inc. Delaware 000-3123 33-0885775 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Identification No.) No. 1 Henglong Road, Yu Qiao Development Zone Shashi District, Jing Zhou City Hubei Province People’s Republic of China (86) 27-5981]

By info| 2016-03-28T19:11:39+00:00 November 12th, 2009|Categories: CAAS, Chinese Stocks, SEC Original|Tags: 0001157762, 2009-11-12, 3714, 8-K, CAAS, MOTOR VEHICLE PARTS and ACCESSORIES|0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: China Automotive Systems Reports 2009 Third Quarter Results

[China Automotive Systems Reports 2009 Third Quarter Results - ， - Q3 EPS $0.28 - Free Cash Flow $15.5 million in first 9 months - WUHAN, China, November 12, 2009 -- China Automotive Systems, Inc., (the "Company"), (NASDAQ: CAAS) 2009 Third Quarter Highlights: -- Net sales increased organically 75% YoY to a new quarterly sales record of $64.7 million; --] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event reported): November 12, 2009 (November 12, 2009) China Automotive Systems, Inc. Delaware 000-3123 33-0885775 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Identification No.) No. 1 Henglong Road, Yu Qiao Development Zone Shashi District, Jing Zhou City Hubei Province People’s Republic of China (86) 27-5981]

By info| 2016-03-28T19:13:21+00:00 November 12th, 2009|Categories: CAAS, Chinese Stocks, Webplus ver|Tags: 0001157762, 2009-11-12, 3714, 8-K, CAAS, MOTOR VEHICLE PARTS and ACCESSORIES|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. TO PRESENT AT THE BREAN MURRAY, CARRET & CO. CHINA GROWTH CONFERENCE Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Wednesday November 4, 2009 BSPM News ; XIANYANG, China, Nov. 4 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: Mr. Ronghua Wang, Chief Executive Officer and Ms. Elaine Zhao, Chief Financial Officer, are scheduled to] [BIOSTAR PHARMACEUTICALS ANNOUNCES CLOSING OF A $3.6 MILLION EQUITY FINANCING Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Friday November 6, 2009 BSPM News ; XIANYANG, China, Nov. 6 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: After completing this transaction, Biostar has approximately 26.1 million shares outstanding on a diluted basis. "After evaluating several financing options to] [BIOSTAR PHARMACEUTICALS, INC. TO HOST FISCAL YEAR 2009 THIRD QUARTER EARNINGS CONFERENCE CALL ON THURSDAY, NOVEMBER 12, 2009 AT 9:30 A.M. ET Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Monday November 9, 2009 BSPM News ; XIANYANG, China, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: http://www.viavid.net http://viavid.net/dce.aspx?sid=00006CE5 http://www.microsoft.com/windows/windowsmedia/en/download/default.asp This call is being web cast]

By info| 2016-03-03T15:37:25+00:00 November 9th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2009-11-09, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. TO PRESENT AT THE BREAN

[BIOSTAR PHARMACEUTICALS, INC. TO PRESENT AT THE BREAN MURRAY, CARRET & CO. CHINA GROWTH CONFERENCE Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Wednesday November 4, 2009 BSPM News ; XIANYANG, China, Nov. 4 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: Mr. Ronghua Wang, Chief Executive Officer and Ms. Elaine Zhao, Chief Financial Officer, are scheduled to] [BIOSTAR PHARMACEUTICALS ANNOUNCES CLOSING OF A $3.6 MILLION EQUITY FINANCING Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Friday November 6, 2009 BSPM News ; XIANYANG, China, Nov. 6 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: After completing this transaction, Biostar has approximately 26.1 million shares outstanding on a diluted basis. "After evaluating several financing options to] [BIOSTAR PHARMACEUTICALS, INC. TO HOST FISCAL YEAR 2009 THIRD QUARTER EARNINGS CONFERENCE CALL ON THURSDAY, NOVEMBER 12, 2009 AT 9:30 A.M. ET Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Monday November 9, 2009 BSPM News ; XIANYANG, China, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: http://www.viavid.net http://viavid.net/dce.aspx?sid=00006CE5 http://www.microsoft.com/windows/windowsmedia/en/download/default.asp This call is being web cast]

By info| 2016-03-03T15:39:44+00:00 November 9th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2009-11-09, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[Skystar Bio-Pharmaceutical Company Announces Two-for-One Stock Split XI'AN, CHINA — November 5, 2009 — Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) Shareholders of record as of the close of market on November 16, 2009 will automatically be entitled to one additional share of common stock for each share owned. No action is required on the part of the shareholders, as the Company’s]

By info| 2016-03-01T07:04:25+00:00 November 5th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2009-11-05, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: Skystar Bio-Pharmaceutical Company Announces Two-for-One Stock Split XI’AN,

[Skystar Bio-Pharmaceutical Company Announces Two-for-One Stock Split XI'AN, CHINA — November 5, 2009 — Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) Shareholders of record as of the close of market on November 16, 2009 will automatically be entitled to one additional share of common stock for each share owned. No action is required on the part of the shareholders, as the Company’s]

By info| 2016-03-01T07:05:35+00:00 November 5th, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 2009-11-05, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments